Finance

Lists
KILITCH:NSE
Kilitch Drugs (India) Ltd
244,25 ₹
-0,02%
(-0,050) 1D
9 қаз., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for KILITCH...
Open
242,50 ₹
High
253,99 ₹
Low
236,20 ₹
Mkt. cap
8,50 млрд
Avg. vol.
61,20 мың
Volume
61,60 мың
P/E ratio
28,02
52-wk high
267,90 ₹
52-wk low
117,25 ₹
EPS
8,72 ₹
Shares outstanding
15,36 млн
No. of employees
236
Open
242,50 ₹
High
253,99 ₹
Low
236,20 ₹
Mkt. cap
8,50 млрд
Avg. vol.
61,20 мың
Volume
61,60 мың
P/E ratio
28,02
52-wk high
267,90 ₹
52-wk low
117,25 ₹
EPS
8,72 ₹
Shares outstanding
15,36 млн
No. of employees
236
News stories
From web sources and news partners
About Kilitch Drugs (India) Ltd
CEO-
Employees236
Founded1978
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
489,24 млн
538,08 млн
896,03 млн
448,79 млн
Cost of goods sold
263,62 млн
308,88 млн
447,19 млн
237,18 млн
Cost of revenue
263,62 млн
308,88 млн
447,19 млн
237,18 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
90,30 млн
88,94 млн
95,23 млн
93,34 млн
Operating expense
183,84 млн
177,06 млн
224,31 млн
193,19 млн
Total operating expenses
447,46 млн
485,93 млн
671,50 млн
430,36 млн
Operating income
41,78 млн
52,15 млн
224,52 млн
18,42 млн
Other non operating income
66,60 млн
15,28 млн
-101,14 млн
28,97 млн
EBT including unusual items
93,99 млн
55,96 млн
202,11 млн
38,63 млн
EBT excluding unusual items
93,99 млн
55,96 млн
174,31 млн
38,63 млн
Income tax expense
13,59 млн
12,81 млн
53,28 млн
18,96 млн
Effective tax rate
14,46%
22,89%
26,36%
49,07%
Other operating expenses
84,92 млн
78,74 млн
127,70 млн
88,92 млн
Net income
81,90 млн
44,32 млн
145,18 млн
29,13 млн
Net profit margin
16,74%
8,24%
16,20%
6,49%
Earnings per share
-
-
-
-
Interest and investment income
-
-
5,47 млн
-
Interest expense
-14,40 млн
-11,47 млн
-14,44 млн
-8,76 млн
Net interest expenses
-14,40 млн
-11,47 млн
-8,97 млн
-8,76 млн
Depreciation and amortization charges
8,63 млн
9,37 млн
1,38 млн
10,93 млн
EBITDA
50,31 млн
57,40 млн
231,03 млн
24,93 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары